Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells
- PMID: 26274999
- DOI: 10.3171/2014.12.JNS1426
Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells
Abstract
OBJECT Increased levels of H19 long noncoding RNA (lncRNA) have been observed in many cancers, suggesting that overexpression of H19 may be important in the development of carcinogenesis. However, the role of H19 in human glioblastoma is still unclear. The object of this study was to examine the level of H19 in glioblastoma samples and investigate the role of H19 in glioblastoma carcinogenesis. METHODS Glioblastoma and nontumor brain tissue specimens were obtained from tissue obtained during tumor resection in 30 patients with glioblastoma. The level of H19 lncRNA was detected by real-time quantitative reverse transcription polymerase chain reaction. The role of H19 in invasion, angiogenesis, and stemness of glioblastoma cells was then investigated using commercially produced cell lines (U87 and U373). The effects of H19 overexpression on glioblastoma cell invasion and angiogenesis were detected by in vitro Matrigel invasion and endothelial tube formation assay. The effects of H19 on glioblastoma cell stemness and tumorigenicity were investigated by neurosphere formation and an in vivo murine xenograft model. RESULTS The authors found that H19 is significantly overexpressed in glioblastoma tissues, and the level of expression was associated with patient survival. In the subsequent investigations, the authors found that overexpression of H19 promotes glioblastoma cell invasion and angiogenesis in vitro. Interestingly, H19 was also significantly overexpressed in CD133(+) glioblastoma cells, and overexpression of H19 was associated with increased neurosphere formation of glioblastoma cells. Finally, stable overexpression of H19 was associated with increased tumor growth in the murine xenograft model. CONCLUSIONS The results of this study suggest that increased expression of H19 lncRNA promotes invasion, angiogenesis, stemness, and tumorigenicity of glioblastoma cells. Taken together, these findings indicate that H19 plays an important role in tumorigenicity and stemness of glioblastoma and thus could be a therapeutic target for treatment of glioblastoma in the future.
Keywords: FBS = fetal bovine serum; H19; HCC = hepatocellular carcinoma; HUVEC = human umbilical vein endothelial cell; RT-qPCR = real-time quantitative reverse transcription polymerase chain reaction; SD = standard deviation; angiogenesis; glioblastoma; invasion; lncRNA = long noncoding RNA; long noncoding RNA; mouse; ncRNA = noncoding RNA; oncology; stemness.
Similar articles
-
Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells.J Neurosurg. 2016 Jan;2016(1):129-136. doi: 10.3171/2014.12.JNS1426.test. J Neurosurg. 2016. PMID: 28306408
-
Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.Mol Carcinog. 2009 Oct;48(10):910-9. doi: 10.1002/mc.20541. Mol Carcinog. 2009. PMID: 19326372
-
Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.Cancer Lett. 2015 Apr 1;359(1):75-86. doi: 10.1016/j.canlet.2014.12.051. Epub 2015 Jan 8. Cancer Lett. 2015. PMID: 25578780
-
Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.Dig Dis. 2014;32(6):778-85. doi: 10.1159/000368021. Epub 2014 Oct 29. Dig Dis. 2014. PMID: 25376296 Review.
-
CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.Neurosurg Clin N Am. 2012 Jul;23(3):391-405. doi: 10.1016/j.nec.2012.04.011. Epub 2012 Jun 5. Neurosurg Clin N Am. 2012. PMID: 22748652 Review.
Cited by
-
Expression of lncRNAs in glioma: A lighthouse for patients with glioma.Heliyon. 2024 Jan 24;10(3):e24799. doi: 10.1016/j.heliyon.2024.e24799. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322836 Free PMC article. Review.
-
Engineered smart materials for RNA based molecular therapy to treat Glioblastoma.Bioact Mater. 2023 Nov 27;33:396-423. doi: 10.1016/j.bioactmat.2023.11.007. eCollection 2024 Mar. Bioact Mater. 2023. PMID: 38059120 Free PMC article.
-
Extracellular Vesicles: New Classification and Tumor Immunosuppression.Biology (Basel). 2023 Jan 10;12(1):110. doi: 10.3390/biology12010110. Biology (Basel). 2023. PMID: 36671802 Free PMC article. Review.
-
T cell exhaustion assessment algorism in tumor microenvironment predicted clinical outcomes and immunotherapy effects in glioma.Front Genet. 2022 Dec 2;13:1087434. doi: 10.3389/fgene.2022.1087434. eCollection 2022. Front Genet. 2022. PMID: 36531217 Free PMC article.
-
Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.Clin Exp Med. 2023 Sep;23(5):1425-1440. doi: 10.1007/s10238-022-00947-5. Epub 2022 Dec 9. Clin Exp Med. 2023. PMID: 36484927 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
